Loophole in U.S. Customs Law Contributing to Fentanyl Deaths
Last year, more than 73,000 Americans died from an overdose of the synthetic opioid fentanyl. The drug itself is cheap and readily available, with thousands of pounds flowing into
CPA Applauds Congresswoman Tenney’s PILLS Act, Legislation to Boost U.S. Domestic Production of Generic Medicines
WASHINGTON — The Coalition for a Prosperous America (CPA) today applauded the introduction of the Producing Incentives for Long-term Production of Lifesaving Supply of Medicines
U.S. Solar Industry Threatened by China’s Overproduction
Chinese solar manufacturers could take advantage of the Inflation Reduction Act’s tax credits by opening plants in the United States.
Written Testimony Before The House Homeland Security Subcommittee on Oversight, Investigations, and Accountability: Exploitation And Enforcement: Evaluating the Department of Homeland Security’s Efforts to Counter Uyghur Forced Labor
The following written testimony was submitted by Michael Stumo, CEO of CPA, to the House Homeland Security Subcommittee on Oversight, Investigations, and Accountability in a
Government Incentives Needed To Reshore Critical Supply Chains, From Pharmaceuticals to Minerals
The U.S. China Economic & Security Review Commission heard from witnesses about keeping auto tariffs on China, and more incentives for manufacturing to reshore.
Falsehoods & Facts: The Truth About De Minimis
Background De minimis is a regulatory loophole. It was morphed from a tiny customs administrative exception into a backdoor superhighway through our ports. The regulatory
Venture Capital CEO Tells House Committee He Agrees With Outbound Investment Restrictions
In latest House Select Committee on the CCP, outbound investment restrictions get favorable view.
Candidate Trump Announces Plans to Reshore Essential Medicines to Avoid Drug Shortages
Trump’s call to reshore pharmaceutical production, especially critical medicine in short supply, will set the table for other presidential candidates. Reshoring America’s medicine supply chain is increasingly mainstream, and an easy sell to voters.
FDA Allows Uninspected China Lab to Sell Cancer Drugs in the US
A Chinese cancer drug maker that has not been inspected by the FDA since 2018 is selling chemotherapy drugs to the U.S. due to shortages. When will the U.S. meet its critical medication needs?
To Fight Drug Shortages FDA Has an Idea: Import More Inspection-Free Drugs
The balance between scarcity and supply favors supply, even if that means importing drugs from labs the FDA has not inspected.
